Hitoshi Maeshima

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review.

Hypoxia-inducible factors enhance glutamate signaling in cancer cells

Depression

Cognitive impairment in euthymic major depressive disorder: a meta-analysis

Major depressive disorder

Functional significance of glutamate–cysteine ligase modifier for erythrocyte survival in vitro and in vivo

Glutamate Receptor Ion Channels: Structure, Regulation, and Function

Glutamate Receptor GRIA3—Target of CUX1 and Mediator of Tumor Progression in Pancreatic Cancer

Commentary: Genome-based CNS drug discovery: d-Amino acid oxidase (DAAO) as a novel target for antipsychotic medications: Progress and challenges

Antioxidants as potential therapeutics for neuropsychiatric disorders

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)

Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

The role of short-chain fatty acids in microbiota–gut–brain communication

The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia

Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death

Changes of Serum Concentrations of Brain-Derived Neurotrophic Factor (BDNF) during Treatment with Venlafaxine and Mirtazapine: Role of Medication and Response to Treatment

Large-Scale Network Dysfunction in Major Depressive Disorder

Executive dysfunction in medicated, remitted state of major depression

No association between glutathione‐synthesis‐related genes and Japanese schizophrenia

Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia

Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression

DURATION OF LAST DEPRESSIVE EPISODE MAY INFLUENCE SERUM BDNF LEVELS IN REMITTED PATIENTS WITH MAJOR DEPRESSION

Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)

Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia — Juntendo University Schizophrenia Projects (JUSP)